Axis Nifty Healthcare ETF
Category: ETFs
Launch Date: 17-05-2021
AUM:
₹ 23.67 Cr
Expense Ratio
0.44%
Benchmark
Nifty Healthcare TRI
ISIN
INF846K01Z12
Minimum Investment
5000.0
Minimum Topup
0.0
Minimum SIP Amount
1000
Fund Manager
Nandik Malik, Rohit Gautam
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Axis Nifty Healthcare ETF | 7.23 | 19.94 | 13.06 |
| NIFTY Healthcare TRI | 7.63 | 20.42 | 13.45 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
161.9413
Last change
2.63 (1.6253%)
Fund Size (AUM)
₹ 23.67 Cr
Performance
12.86% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the Scheme is to provide returns before expenses that closely correspond to the total returns of the NIFTY Healthcare Index subject to tracking errors. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved.
Fund Manager
Nandik Malik, Rohit Gautam
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 17.0 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 10.44 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.43 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 6.82 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.69 |
| Dr. Reddys Laboratories Ltd | 6.65 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 6.24 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 6.12 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.36 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.08 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.99 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Axis Nifty Healthcare ETF | 13.06 |